HGH Fragment 176-191 (Protein Peptide – Fragment 176-191) – 2MG per vial

Clinical Test Expectation – HGH Fragment 176-191 5MG (Protein Peptide – Fragment 176-191) – Human Subjects : Anti obesity peptide that reduces cumulative body weight gain, and decreased the adipose tissue mass.
Strength – 5MG per vial

Introduction
hGH Fragment 176-191 is often referred to as the “lipolytic fragment” for its ability to boost fat loss. It has been shown to help lowers blood sugar levels and promote cartilage healing without increasing long bone growth, increasing IGF-1 levels, or altering insulin sensitivity.Fragment 176-191 (modified version of AOD9604) is a small piece of human growth hormone (hGH) that is sometimes referred to as the lipolytic fragment. Fragment 176-191 earned this latter name due to the fact that laboratory research has shown it to enhance fat burning, particularly in mice genetically engineered to produce large fat stores. Fragment 176-191 has been heavily researched in animal models because even while it preserves the fat-burning effects of hGH, it avoids some other effects of its parent protein such as increasing insulin-like growth factor-1 (IGF-1) levels, negatively impacting carbohydrate metabolism, altering insulin sensitivity, increasing long bone growth, and so forth. The targeted effects of fragment 176-191 make it useful for exploring human fat metabolism and may eventually provide the basis for developing anti-obesity medications.

Results indicate that the hGH Fragment 176-191 reduced the cumulative body weight gain, and decreased the adipose tissue mass.

Dosing Details – Please visit this link for Dosing instructions : https://researchpeptides.co.za/dosage-instructions/